Facilitating Neuroplastic Changes of Acute Stroke Survivors
Launched by UNIVERSITY OF MARYLAND, BALTIMORE · May 3, 2024
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new wearable robot designed to help stroke survivors recover while they are still in bed. The goal is to assist with rehabilitation for patients who have had a stroke, especially those who may not be able to move their limbs at all. The robot will guide patients through exercises to help them regain movement and improve their motor skills, even in the early stages of recovery, which can start as soon as 24 hours after the stroke.
To be eligible for this trial, participants must be between the ages of 30 and 85 and have experienced a first-time stroke affecting one side of the body. They should have some difficulty moving their limbs, specifically with their ankles. However, those who are medically unstable or have certain other medical issues will not be able to participate. If enrolled, participants can expect to use the wearable robot during their rehabilitation sessions, which will focus on helping them relearn how to move and use their affected limbs. This trial is not yet recruiting participants, but it aims to bring new hope for recovery in stroke survivors.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Acute first time unilateral hemispheric stroke (hemorrhagic or ischemic stroke, 24 hours after admission to 1 month post-stroke at the start of the proposed treatment)
- • Hemiplegia or hemiparesis
- • 0≤Manual Muscle Testing (MMT)\<=2
- • Age 30-85
- • Ankle impairments including stiff calf muscles and/or inadequate dorsiflexion
- Exclusion Criteria:
- • Medically not stable
- • Associated acute medical illness that interferes with ability to training and exercise
- • No impairment or very mild ankle impairment of ankle
- • Severe cardiovascular problems that interfere with ability to perform moderate movement exercises
- • Cognitive impairment or aphasia with inability to follow instructions
- • Severe pain in legs
- • Severe ankle contracture greater than 15° plantar flexion (when pushing ankle to dorsiflexion)
- • Pressure ulcer, recent surgical incision or active skin disease with open wounds present below knee
About University Of Maryland, Baltimore
The University of Maryland, Baltimore (UMB) is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, UMB leverages its extensive resources and expertise across various disciplines, including medicine, pharmacy, nursing, and social work, to contribute to groundbreaking discoveries and improve patient outcomes. Committed to ethical research practices and collaboration, UMB fosters an environment that promotes the translation of scientific knowledge into real-world applications, ultimately enhancing the well-being of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Baltimore, Maryland, United States
Patients applied
Trial Officials
Li-Qun Zhang
Principal Investigator
University of Maryland
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported